Sikandar Mesiya, MD
Gastroenterology · Midwest City, OKNPI 1407830342
Payments from drug & device makers
Across 634 payments — averaging $16.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Johnson & Johnson$2K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Gilead$708
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$500
- Pfizer$437
- plus $3K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 210 | $3,603 |
| Johnson & Johnson | 105 | $1,590 |
| Takeda Pharmaceuticals U.S.A., Inc. | 74 | $1,286 |
| Gilead | 44 | $708 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 33 | $500 |
| Pfizer | 28 | $437 |
| Bristol Myers Squibb | 31 | $426 |
| Sanofi | 21 | $374 |
| Intercept Pharmaceuticals, Inc. | 14 | $235 |
| Lilly USA, LLC | 7 | $179 |
| Aimmune Therapeutics, Inc. | 8 | $150 |
| Nestle Healthcare Nutrition Inc. | 7 | $141 |
| Regeneron Healthcare Solutions, Inc. | 5 | $118 |
| Ironwood Pharmaceuticals, Inc | 6 | $101 |
| Celltrion USA Inc. | 4 | $98 |
| Janssen Scientific Affairs, LLC | 1 | $89 |
| Medtronic | 2 | $89 |
| Merck | 6 | $87 |
| Ipsen Biopharmaceuticals, Inc | 4 | $65 |
| Ardelyx, Inc. | 4 | $62 |
| Vivus LLC | 2 | $45 |
| QOL Medical, LLC | 3 | $41 |
| Redhill Biopharma Inc. | 3 | $41 |
| Braintree Laboratories, Inc. | 2 | $35 |
| Amgen | 2 | $34 |
| Madrigal Pharmaceuticals | 1 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $21 |
| Dynavax Technologies Corporation | 1 | $21 |
| Organon | 2 | $21 |
| Fresenius Kabi USA, LLC | 1 | $18 |
| Micro-tech Endoscopy USA, Inc. | 1 | $9 |
How this compares
$10,654 in reported general payments places this provider in the 65th percentile of 133 gastroenterology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Midwest City
- Baolong NguyenMidwest City$74K
- Larry BookmanMidwest City$7K
- Harvey TatumTulsa$2.6M
- Tauseef AliOklahoma City$2.1M
- David StokesberryOklahoma City$1.7M
- George SalemOklahoma City$1.2M
- Matthew McBrideOklahoma City$741K
- Richard HartyOklahoma City$462K
- Aaron FiekerTulsa$232K
- Kevin McNamaraTulsa$223K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.